Loading…

Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study

•This is a sub-analysis from the NIPPON storm study, a multicenter cohort study in Japan.•Atrial fibrillation/flutter (AF) is an independent risk factor for all-cause death and inappropriate implantable cardioverter-defibrillator therapy.•Incidence of sudden death and arrhythmic death is higher in p...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiology 2021-09, Vol.78 (3), p.244-249
Main Authors: Maruyama, Masahiro, Yasuoka, Ryobun, Nagano, Tomoya, Nakazawa, Gaku, Noda, Takashi, Nitta, Takashi, Aizawa, Yoshifusa, Ohe, Tohru, Kurita, Takashi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c508t-c823cfbedbf3327cb8ed358e44e841d930305c3422cff6c588421f458953bb083
cites cdi_FETCH-LOGICAL-c508t-c823cfbedbf3327cb8ed358e44e841d930305c3422cff6c588421f458953bb083
container_end_page 249
container_issue 3
container_start_page 244
container_title Journal of cardiology
container_volume 78
creator Maruyama, Masahiro
Yasuoka, Ryobun
Nagano, Tomoya
Nakazawa, Gaku
Noda, Takashi
Nitta, Takashi
Aizawa, Yoshifusa
Ohe, Tohru
Kurita, Takashi
description •This is a sub-analysis from the NIPPON storm study, a multicenter cohort study in Japan.•Atrial fibrillation/flutter (AF) is an independent risk factor for all-cause death and inappropriate implantable cardioverter-defibrillator therapy.•Incidence of sudden death and arrhythmic death is higher in patients with AF. Implantable cardioverter-defibrillator and cardiac resynchronization therapy using a defibrillator (ICD/CRT-D) are established means of reducing mortality due to ventricular arrhythmia. Although atrial fibrillation/flutter (AF) is the most common cardiac arrhythmia in patients with heart disease, the impact of AF on the prognosis of patients with ICD/CRT-D remains controversial. We analyzed data from the Nippon Storm Study, a prospective observational study of 1570 patients that was conducted at 48 Japanese ICD centers. We allocated 1549 participants to AF and non-AF groups, compared their clinical data at the time of enrollment, and monitored the incidences of mortality, hospitalization, and appropriate and inappropriate ICD/CRT-D therapy during a median 28 months. When the AF (n = 257, 16.6%) and non-AF-(n = 1292, 83.4%) groups were compared, the AF group was older (67.7 vs. 61.4 years; p
doi_str_mv 10.1016/j.jjcc.2021.04.003
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2522190725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0914508721000915</els_id><sourcerecordid>2522190725</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-c823cfbedbf3327cb8ed358e44e841d930305c3422cff6c588421f458953bb083</originalsourceid><addsrcrecordid>eNp9kc1u1TAQRi0EopfCC7BAXrJJ6r8kDmJTVVAqVbAA1pbtjFVHSRxsp-i-Bw-M01u6ZOXFnO_IMx9CbympKaHtxViPo7U1I4zWRNSE8GfoQGXXVqLj8jk6kJ6KqiGyO0OvUhoJaUkv25fojPNeUMH6A_pzM6_aZhwc1jl6PWHnTfTTpLMPy4Wbtpwh4rDgsGUbZkg7upYpLDnh3z7fYT-vk16yNhNgq-Pgwz3EPTXAkyzE9AFf4rSZSi96Oib_IMp3gL_6dS3-74WZccrbcHyNXjg9JXjz-J6jn58__bj6Ut1-u765urytbFkqV1Yybp2BwTjOWWeNhIE3EoQAKejQc8JJY7lgzDrX2kZKwagTjewbbgyR_By9P3nXGH5tkLKafbJQ_rtA2JJiDWO0Jx1rCspOqI0hpQhOrdHPOh4VJWpvQ41qb0PtbSgiVGmjhN49-jczw_AU-Xf-Anw8AVC2vPcQVbLlsBYGH8FmNQT_P_9fg_Oenw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2522190725</pqid></control><display><type>article</type><title>Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study</title><source>ScienceDirect Journals</source><creator>Maruyama, Masahiro ; Yasuoka, Ryobun ; Nagano, Tomoya ; Nakazawa, Gaku ; Noda, Takashi ; Nitta, Takashi ; Aizawa, Yoshifusa ; Ohe, Tohru ; Kurita, Takashi</creator><creatorcontrib>Maruyama, Masahiro ; Yasuoka, Ryobun ; Nagano, Tomoya ; Nakazawa, Gaku ; Noda, Takashi ; Nitta, Takashi ; Aizawa, Yoshifusa ; Ohe, Tohru ; Kurita, Takashi</creatorcontrib><description>•This is a sub-analysis from the NIPPON storm study, a multicenter cohort study in Japan.•Atrial fibrillation/flutter (AF) is an independent risk factor for all-cause death and inappropriate implantable cardioverter-defibrillator therapy.•Incidence of sudden death and arrhythmic death is higher in patients with AF. Implantable cardioverter-defibrillator and cardiac resynchronization therapy using a defibrillator (ICD/CRT-D) are established means of reducing mortality due to ventricular arrhythmia. Although atrial fibrillation/flutter (AF) is the most common cardiac arrhythmia in patients with heart disease, the impact of AF on the prognosis of patients with ICD/CRT-D remains controversial. We analyzed data from the Nippon Storm Study, a prospective observational study of 1570 patients that was conducted at 48 Japanese ICD centers. We allocated 1549 participants to AF and non-AF groups, compared their clinical data at the time of enrollment, and monitored the incidences of mortality, hospitalization, and appropriate and inappropriate ICD/CRT-D therapy during a median 28 months. When the AF (n = 257, 16.6%) and non-AF-(n = 1292, 83.4%) groups were compared, the AF group was older (67.7 vs. 61.4 years; p&lt;0.0001), and had lower left ventricular ejection fraction (38.0 ± 17.0% vs. 43.5 ± 18.9%; p&lt;0.0001). During follow up, mortality was significantly higher in the AF than the non-AF group (p&lt;0.0001). In multivariate analysis, AF was significantly associated with all-cause mortality [p = 0.013; hazard ratio (HR)=1.62]. Inappropriate ICD/CRT-D therapy occurred in 40/257 patients (15.6%) and AF was associated with a higher prevalence of inappropriate ICD/CRT-D therapy (p&lt;0.0001; HR=2.25). The presence of AF at ICD/CRT-D implantation carries subsequent independent risks of 1.62-fold for death and 2.25-fold for inappropriate therapy.</description><identifier>ISSN: 0914-5087</identifier><identifier>EISSN: 1876-4738</identifier><identifier>DOI: 10.1016/j.jjcc.2021.04.003</identifier><identifier>PMID: 33941429</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Atrial fibrillation ; Implantable cardioverter ; Inappropriate therapy ; Mortality ; Nippon Storm study</subject><ispartof>Journal of cardiology, 2021-09, Vol.78 (3), p.244-249</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-c823cfbedbf3327cb8ed358e44e841d930305c3422cff6c588421f458953bb083</citedby><cites>FETCH-LOGICAL-c508t-c823cfbedbf3327cb8ed358e44e841d930305c3422cff6c588421f458953bb083</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33941429$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maruyama, Masahiro</creatorcontrib><creatorcontrib>Yasuoka, Ryobun</creatorcontrib><creatorcontrib>Nagano, Tomoya</creatorcontrib><creatorcontrib>Nakazawa, Gaku</creatorcontrib><creatorcontrib>Noda, Takashi</creatorcontrib><creatorcontrib>Nitta, Takashi</creatorcontrib><creatorcontrib>Aizawa, Yoshifusa</creatorcontrib><creatorcontrib>Ohe, Tohru</creatorcontrib><creatorcontrib>Kurita, Takashi</creatorcontrib><title>Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study</title><title>Journal of cardiology</title><addtitle>J Cardiol</addtitle><description>•This is a sub-analysis from the NIPPON storm study, a multicenter cohort study in Japan.•Atrial fibrillation/flutter (AF) is an independent risk factor for all-cause death and inappropriate implantable cardioverter-defibrillator therapy.•Incidence of sudden death and arrhythmic death is higher in patients with AF. Implantable cardioverter-defibrillator and cardiac resynchronization therapy using a defibrillator (ICD/CRT-D) are established means of reducing mortality due to ventricular arrhythmia. Although atrial fibrillation/flutter (AF) is the most common cardiac arrhythmia in patients with heart disease, the impact of AF on the prognosis of patients with ICD/CRT-D remains controversial. We analyzed data from the Nippon Storm Study, a prospective observational study of 1570 patients that was conducted at 48 Japanese ICD centers. We allocated 1549 participants to AF and non-AF groups, compared their clinical data at the time of enrollment, and monitored the incidences of mortality, hospitalization, and appropriate and inappropriate ICD/CRT-D therapy during a median 28 months. When the AF (n = 257, 16.6%) and non-AF-(n = 1292, 83.4%) groups were compared, the AF group was older (67.7 vs. 61.4 years; p&lt;0.0001), and had lower left ventricular ejection fraction (38.0 ± 17.0% vs. 43.5 ± 18.9%; p&lt;0.0001). During follow up, mortality was significantly higher in the AF than the non-AF group (p&lt;0.0001). In multivariate analysis, AF was significantly associated with all-cause mortality [p = 0.013; hazard ratio (HR)=1.62]. Inappropriate ICD/CRT-D therapy occurred in 40/257 patients (15.6%) and AF was associated with a higher prevalence of inappropriate ICD/CRT-D therapy (p&lt;0.0001; HR=2.25). The presence of AF at ICD/CRT-D implantation carries subsequent independent risks of 1.62-fold for death and 2.25-fold for inappropriate therapy.</description><subject>Atrial fibrillation</subject><subject>Implantable cardioverter</subject><subject>Inappropriate therapy</subject><subject>Mortality</subject><subject>Nippon Storm study</subject><issn>0914-5087</issn><issn>1876-4738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1TAQRi0EopfCC7BAXrJJ6r8kDmJTVVAqVbAA1pbtjFVHSRxsp-i-Bw-M01u6ZOXFnO_IMx9CbympKaHtxViPo7U1I4zWRNSE8GfoQGXXVqLj8jk6kJ6KqiGyO0OvUhoJaUkv25fojPNeUMH6A_pzM6_aZhwc1jl6PWHnTfTTpLMPy4Wbtpwh4rDgsGUbZkg7upYpLDnh3z7fYT-vk16yNhNgq-Pgwz3EPTXAkyzE9AFf4rSZSi96Oib_IMp3gL_6dS3-74WZccrbcHyNXjg9JXjz-J6jn58__bj6Ut1-u765urytbFkqV1Yybp2BwTjOWWeNhIE3EoQAKejQc8JJY7lgzDrX2kZKwagTjewbbgyR_By9P3nXGH5tkLKafbJQ_rtA2JJiDWO0Jx1rCspOqI0hpQhOrdHPOh4VJWpvQ41qb0PtbSgiVGmjhN49-jczw_AU-Xf-Anw8AVC2vPcQVbLlsBYGH8FmNQT_P_9fg_Oenw</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Maruyama, Masahiro</creator><creator>Yasuoka, Ryobun</creator><creator>Nagano, Tomoya</creator><creator>Nakazawa, Gaku</creator><creator>Noda, Takashi</creator><creator>Nitta, Takashi</creator><creator>Aizawa, Yoshifusa</creator><creator>Ohe, Tohru</creator><creator>Kurita, Takashi</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210901</creationdate><title>Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study</title><author>Maruyama, Masahiro ; Yasuoka, Ryobun ; Nagano, Tomoya ; Nakazawa, Gaku ; Noda, Takashi ; Nitta, Takashi ; Aizawa, Yoshifusa ; Ohe, Tohru ; Kurita, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-c823cfbedbf3327cb8ed358e44e841d930305c3422cff6c588421f458953bb083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Atrial fibrillation</topic><topic>Implantable cardioverter</topic><topic>Inappropriate therapy</topic><topic>Mortality</topic><topic>Nippon Storm study</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maruyama, Masahiro</creatorcontrib><creatorcontrib>Yasuoka, Ryobun</creatorcontrib><creatorcontrib>Nagano, Tomoya</creatorcontrib><creatorcontrib>Nakazawa, Gaku</creatorcontrib><creatorcontrib>Noda, Takashi</creatorcontrib><creatorcontrib>Nitta, Takashi</creatorcontrib><creatorcontrib>Aizawa, Yoshifusa</creatorcontrib><creatorcontrib>Ohe, Tohru</creatorcontrib><creatorcontrib>Kurita, Takashi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maruyama, Masahiro</au><au>Yasuoka, Ryobun</au><au>Nagano, Tomoya</au><au>Nakazawa, Gaku</au><au>Noda, Takashi</au><au>Nitta, Takashi</au><au>Aizawa, Yoshifusa</au><au>Ohe, Tohru</au><au>Kurita, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study</atitle><jtitle>Journal of cardiology</jtitle><addtitle>J Cardiol</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>78</volume><issue>3</issue><spage>244</spage><epage>249</epage><pages>244-249</pages><issn>0914-5087</issn><eissn>1876-4738</eissn><abstract>•This is a sub-analysis from the NIPPON storm study, a multicenter cohort study in Japan.•Atrial fibrillation/flutter (AF) is an independent risk factor for all-cause death and inappropriate implantable cardioverter-defibrillator therapy.•Incidence of sudden death and arrhythmic death is higher in patients with AF. Implantable cardioverter-defibrillator and cardiac resynchronization therapy using a defibrillator (ICD/CRT-D) are established means of reducing mortality due to ventricular arrhythmia. Although atrial fibrillation/flutter (AF) is the most common cardiac arrhythmia in patients with heart disease, the impact of AF on the prognosis of patients with ICD/CRT-D remains controversial. We analyzed data from the Nippon Storm Study, a prospective observational study of 1570 patients that was conducted at 48 Japanese ICD centers. We allocated 1549 participants to AF and non-AF groups, compared their clinical data at the time of enrollment, and monitored the incidences of mortality, hospitalization, and appropriate and inappropriate ICD/CRT-D therapy during a median 28 months. When the AF (n = 257, 16.6%) and non-AF-(n = 1292, 83.4%) groups were compared, the AF group was older (67.7 vs. 61.4 years; p&lt;0.0001), and had lower left ventricular ejection fraction (38.0 ± 17.0% vs. 43.5 ± 18.9%; p&lt;0.0001). During follow up, mortality was significantly higher in the AF than the non-AF group (p&lt;0.0001). In multivariate analysis, AF was significantly associated with all-cause mortality [p = 0.013; hazard ratio (HR)=1.62]. Inappropriate ICD/CRT-D therapy occurred in 40/257 patients (15.6%) and AF was associated with a higher prevalence of inappropriate ICD/CRT-D therapy (p&lt;0.0001; HR=2.25). The presence of AF at ICD/CRT-D implantation carries subsequent independent risks of 1.62-fold for death and 2.25-fold for inappropriate therapy.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33941429</pmid><doi>10.1016/j.jjcc.2021.04.003</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0914-5087
ispartof Journal of cardiology, 2021-09, Vol.78 (3), p.244-249
issn 0914-5087
1876-4738
language eng
recordid cdi_proquest_miscellaneous_2522190725
source ScienceDirect Journals
subjects Atrial fibrillation
Implantable cardioverter
Inappropriate therapy
Mortality
Nippon Storm study
title Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A54%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20atrial%20fibrillation/flutter%20on%20outcomes%20of%20patients%20with%20implantable%20cardioverter%20defibrillators:%20A%20sub-analysis%20of%20the%20Nippon%20Storm%20study&rft.jtitle=Journal%20of%20cardiology&rft.au=Maruyama,%20Masahiro&rft.date=2021-09-01&rft.volume=78&rft.issue=3&rft.spage=244&rft.epage=249&rft.pages=244-249&rft.issn=0914-5087&rft.eissn=1876-4738&rft_id=info:doi/10.1016/j.jjcc.2021.04.003&rft_dat=%3Cproquest_cross%3E2522190725%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c508t-c823cfbedbf3327cb8ed358e44e841d930305c3422cff6c588421f458953bb083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2522190725&rft_id=info:pmid/33941429&rfr_iscdi=true